Literature DB >> 31960069

Understanding resistance in Pseudomonas.

George Dimopoulos1, Murat Akova2, Jordi Rello3,4, Garyphalia Poulakou5.   

Abstract

Entities:  

Year:  2020        PMID： 31960069     DOI： 10.1007/s00134-019-05905-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa.

Authors:  J Rello; P Jubert; J Vallés; A Artigas; M Rué; M S Niederman
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

2.  Infections in intensive care unit adult patients harboring multidrug-resistant Pseudomonas aeruginosa: implications for prevention and therapy.

Authors:  B Borgatta; L Lagunes; A T Imbiscuso; M N Larrosa; M Lujàn; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-16       Impact factor: 3.267

3.  Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN.

Authors:  A G Venier; D Gruson; T Lavigne; P Jarno; F L'hériteau; B Coignard; A Savey; A M Rogues
Journal:  J Hosp Infect       Date:  2011-07-07       Impact factor: 3.926

4.  Fitness cost of antibiotic susceptibility during bacterial infection.

Authors:  Damien Roux; Olga Danilchanka; Thomas Guillard; Vincent Cattoir; Hugues Aschard; Yang Fu; Francois Angoulvant; Jonathan Messika; Jean-Damien Ricard; John J Mekalanos; Stephen Lory; Gerald B Pier; David Skurnik
Journal:  Sci Transl Med       Date:  2015-07-22       Impact factor: 17.956

Review 5.  Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.

Authors:  Matteo Bassetti; Garyphallia Poulakou; Etienne Ruppe; Emilio Bouza; Sebastian J Van Hal; Adrian Brink
Journal:  Intensive Care Med       Date:  2017-07-21       Impact factor: 17.440

Review 6.  Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.

Authors:  Nicholas M Maurice; Brahmchetna Bedi; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

7.  Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines.

Authors:  C Solé-Lleonart; J A Roberts; J Chastre; G Poulakou; L B Palmer; S Blot; T Felton; M Bassetti; C-E Luyt; J M Pereira; J Riera; T Welte; H Qiu; J-J Rouby; J Rello
Journal:  Clin Microbiol Infect       Date:  2015-12-23       Impact factor: 8.067

Review 8.  Emerging therapies against infections with Pseudomonas aeruginosa.

Authors:  Burkhard Tümmler
Journal:  F1000Res       Date:  2019-08-07

9.  Mutations in pmrB Confer Cross-Resistance between the LptD Inhibitor POL7080 and Colistin in Pseudomonas aeruginosa.

Authors:  Keith P Romano; Thulasi Warrier; Bradley E Poulsen; Phuong H Nguyen; Alexander R Loftis; Azin Saebi; Bradley L Pentelute; Deborah T Hung
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

Review 10.  Beyond Antagonism: The Interaction Between Candida Species and Pseudomonas aeruginosa.

Authors:  Ruan Fourie; Carolina H Pohl
Journal:  J Fungi (Basel)       Date:  2019-04-19
View more
  2 in total

1.  Antimicrobial Activity of Colistin Against Contemporary (2015 - 2017) P. aeruginosa and A. baumannii Isolates From a Chinese Surveillance Program.

Authors:  Hui Zhang; Ge Zhang; Jingjia Zhang; Simeng Duan; Yue Kang; Qiwen Yang; Yingchun Xu
Journal:  Front Microbiol       Date:  2020-09-04       Impact factor: 5.640

2.  IgY Targeting Bacterial Quorum-Sensing Molecules in Implant-Associated Infections.

Authors:  Ulrike Dapunt; Birgit Prior; Christopher Oelkrug; Jan Philippe Kretzer
Journal:  Molecules       Date:  2020-09-03       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.